The complex management of idiopathic pulmonary fibrosis

M3 Global Newsdesk Nov 03, 2018

Researchers recently highlighted ways to improve treatment for idiopathic pulmonary fibrosis (IPF) in an article published in Expert Review of Respiratory Medicine. The authors also examined ongoing research efforts to develop new IPF drug therapies.



 

 

In the past, treatment of IPF relied primarily on immunosuppression with corticosteroids and cell cycle inhibitors—specifically azathioprine. In 2012, however, researchers showed that combination therapy of...

International Medicine Patient Research

Non loggedin lock

To read this article Sign up / Login for free

This article is only available to members. Are you a doctor? Click here to signup for free.